Accessibility Menu
Motus Gi logo

Motus Gi(OTC) MOTS

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2018)-100%
5 Year-100%
1 Year-99%
1 Month-99%
$0.00
+0%
+0.00Today
Motus Gi last closing stock price
MetricPriceDate
Last closeUSD 0.002026-07-22
Motus Gi stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-07-15
1 month-99%USD 0.002026-06-17
3 month-99%USD 0.002026-04-21
Year to date-99%USD 0.002025-12-31
1 year-99%USD 0.002025-07-22
3 year-100%USD 10.202023-07-21
5 year-100%USD 280.562021-07-23
Since inception-100%USD 1,314.002018-02-14

Motus Gi Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$327.00K

Net Income (TTM)

-$10.59M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-12.05 (Low)

Price

$0.00

Volume

3

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.10

Estimated Earnings Date

May 29, 2026

MOTS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Motus Gi

Motus GI Holdings, Inc. is a medical technology company focused on developing innovative solutions for gastrointestinal procedures. The company is known for its Pure-Vu system, which enhances the cleansing of poorly prepared gastrointestinal tracts during colonoscopy and upper gastrointestinal endoscopy procedures.

Products and Services
  • Pure-Vu system for gastrointestinal tract cleansing
  • Innovative medical devices for endoscopic procedures
  • Research and development in gastrointestinal technologies
Growth Outlook
  • Significant market potential in gastrointestinal procedures
  • Increased focus on improving patient outcomes and procedural efficiency
  • Expansion opportunities in the medical device sector
Financial Highlights
  • Q1 2024 revenue of $64,000, consistent with previous quarter
  • Net income for Q1 2024 was -$2,113,000, reflecting ongoing investment
  • Cash and cash equivalents at $4,944,000, providing operational liquidity
Motus GI Holdings, Inc. operates in a niche market with a focus on enhancing gastrointestinal procedures through innovative technology. The Pure-Vu system addresses a critical need in the medical field, potentially improving patient outcomes and procedural efficiency. The company is positioned for growth, with opportunities to expand its market presence and product offerings. Recent financial data indicates a commitment to research and development, although the company continues to operate at a loss as it invests in future growth. The current cash position provides a buffer for ongoing operations and development initiatives.
AI Generated • Jul 21, 2026

Industry

Healthcare Equipment and Supplies

Employees

15

CEO

Mark Pomeranz

Headquarters

Fort Lauderdale, FL 33301, US

MOTS Financials

Key Financial Metrics (TTM)

Gross Margin

-78.37%

Operating Margin

-3732.60%

Net Income Margin

-4033.54%

Return on Equity

-454.34%

Return on Capital

-230.98%

Return on Assets

-178.14%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

6.39M

Volume

3

Avg. Volume

2.44K

Financials (TTM)

Gross Profit

-$160.00K

Operating Income

-$9.57M

EBITDA

-$9.40M

Operating Cash Flow

-$8.62M

Capital Expenditure

-$65.00K

Free Cash Flow

-$8.68M

Cash & ST Invst.

$4.94M

Total Debt

$2.44M

Motus Gi Performance Analysis

Motus Gi annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 391,000N/A
20222022-12-31USD 592,00051.4%
20232023-12-31USD 319,000-46.1%
Motus Gi sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22023-06-30101.8%
Q32023-09-30-23.9%
Q42023-12-31-25.6%
Q12024-03-31N/A
Motus Gi annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -161.07N/A
20222022-12-31USD -86.15-46.5%
20232023-12-31USD -15.89-81.6%
Motus Gi sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22023-06-3056.9%
Q32023-09-3028.1%
Q42023-12-3157.7%
Q12024-03-3151.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2024YOY CHG

Revenue

$64.00K

+14.3%

Gross Profit

$52.00K

+144.1%

Gross Margin

81.25%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

15

N/A

Net Income

-$2.11M

+51.8%

EBITDA

-$1.88M

+52.4%

Quarterly Fundamentals

Name
Q1 2024YOY CHG

Total Cash

$4.94M

-42.8%

Total Debt

$2.44M

-77.4%

Accounts Receivable

$81.00K

+55.8%

Inventory

$228.00K

-50.9%

Long Term Debt

$690.00K

-91.3%

Short Term Debt

$1.75M

-38.9%

Return on Assets

-1.78%

N/A

Return on Invested Capital

-3.01%

N/A

Free Cash Flow

-$2.02M

+58.2%

Operating Cash Flow

-$2.02M

+57.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ONCSQOncoSec Medical Incorporated
$0.00+0.00%
BIIOBionovate Technologies Corp
$0.00+0.00%
ROSGQRosetta Genomics Ltd.
$0.00+0.00%
HRALHear AtLast Holdings, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOFISoFi Technologies
$15.25-0.09%
INTCIntel
$81.88-0.05%
NVDANvidia
$190.01-0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$57.75-0.06%

Questions About MOTS

What is the current price of Motus Gi?

Motus Gi is trading at $0.00 per share.

What is the 52-week range for Motus Gi?

Over the past 52 weeks, Motus Gi has traded between $0.00 and $0.10.

How much debt does Motus Gi have?

As of the most recent reporting period, Motus Gi reported total debt of $2.47M.

How much cash does Motus Gi have on hand?

Motus Gi reported $4.96M in cash and cash equivalents in its most recent financial results.

What is Motus Gi’s dividend yield?

Motus Gi does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.